Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 58, Issue 11, Pages 2523-2531
Publisher
Informa UK Limited
Online
2017-03-29
DOI
10.1080/10428194.2017.1306646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis
- (2016) Armin Rashidi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
- (2016) J C Albring et al. BONE MARROW TRANSPLANTATION
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia
- (2015) Claudio Fozza et al. LEUKEMIA RESEARCH
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
- (2015) J L Reagan et al. Blood Cancer Journal
- Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment
- (2013) Holger Krönig et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML
- (2012) G Ramsingh et al. LEUKEMIA
- Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia
- (2011) Djordje Atanackovic et al. AMERICAN JOURNAL OF HEMATOLOGY
- A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
- (2011) M. A. Sekeres et al. BLOOD
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Azacitidine for the treatment of patients with acute myeloid leukemia
- (2011) Luca Maurillo et al. CANCER
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
- (2011) D A Pollyea et al. LEUKEMIA
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
- (2010) T. A. Fehniger et al. BLOOD
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
- (2010) Q. Zhou et al. BLOOD
- Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
- (2010) O. Goodyear et al. BLOOD
- In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
- (2010) Céline Berthon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias
- (2010) William Blum et al. JOURNAL OF CLINICAL ONCOLOGY
- Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010
- (2009) D. Pulte et al. ANNALS OF ONCOLOGY
- Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
- (2009) I. M. Borrello et al. BLOOD
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
- (2009) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13
- (2008) T. A. Fehniger et al. BLOOD
- Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells
- (2008) Rasheed Khan et al. EXPERIMENTAL HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started